 
 
 
Date: September 02, 2023 
 
To,
BSE Limited 
Corporate Relationship Department 
25th Floor, Phiroze Jeejeebhoy Towers 
Dalal Street, Mumbai- 400001 
Scrip Code: 543328 
To,
National Stock Exchange of India Limited 
Exchange Plaza, Plot No. C-1, Block G, 
Sandra Kurla Complex, Bandra (East) 
Mumbai – 400051 
NSE Symbol: KRSNAA 
 
Dear Sir/Madam, 
 
Subject: Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements)  
Regulations, 2015 
 
Pursuant to Regulation 34(2)(f) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,  
2015, we are submitting herewith the Business Responsibility and Sustainability Report (“BRSR”) for 
the Financial Year 2022-23, which also forms part of the Annual Report for the Financial Year 2022-23. 
 
The copy of BRSR is also available on Company's website at https://krsnaadiagnostics.com/investors/  
 
You are requested to take the above information on your record. 
 
For Krsnaa Diagnostics Limited  
 
Sujoy Sudipta Bose 
Company Secretary and Compliance Officer 
 
Encl: as above 
SUJOY 
SUDIPT
A BOSE
Digitally signed by SUJOY SUDIPTA 
BOSE 
DN: c=IN, o=PERSONAL, title=2451, 
pseudonym=b97640325dc4c0db6c69c
1b1edb9cbffd34fb13fffc2a649b18c608
de50ed1c1, postalCode=411027, 
st=Maharashtra, 
serialNumber=be7bf227eed7fd4ea4f78
d237c80a0229c19e89cfaabd62c797b40
30cbe11f93, cn=SUJOY SUDIPTA BOSE 
Date: 2023.09.02 11:32:59 +05'30'
Business Responsibility and Sustainability Report
In terms of Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure 
Requirements) Regulations, 2015 as amended, Business Responsibility and Sustainability Report (BRSR) in the Annual 
Report is mandatory for the top 1,000 listed companies, based on market capitalisation as on March 31 of every year. 
The BRSR is based on the format suggested by SEBI
SECTION A: GENERAL DISCLOSURES
I. 
Details
1
Corporate Identity Number (CIN) of the Listed Entity
L74900PN2010PLC138068
2
Name of the Listed Entity
Krsnaa Diagnostics Limited
3
Year of incorporation
2010
4
S. No. 243/A, Hissa No. 6, CTS No. 4519, 4519/1, 
Near Chinchwad Station, Chinchwad, Taluka, - 
Haveli Pune MH 411019 IN
5
Corporate address
S. No. 243/A, Hissa No. 6, CTS No. 4519, 4519/1, 
Near Chinchwad Station, Chinchwad, Taluka, - 
Haveli Pune MH 411019 IN
6
E-mail
investors@krsnaa.in
7
Telephone
020-27402400
8
Website
https://krsnaadiagnostics.com
9
Date Of Start Of Financial Year
Start Date
End Date
Financial Year
April 1,2022
March 31, 2023
Previous Year
April 1, 2021
March 31, 2022
Prior To Previous Year
April 1, 2020
March 31, 2021
10
Name of the Stock Exchange(s) where shares are 
listed
1. 
BSE Limited
2. 
National Stock Exchange of India Limited
11
Paid-up Capital
15,69,88,065
12
Name and contact details (telephone, email address) of the person who may be contacted in 
case of any queries on the BRSR report
Name Of Contact Person
Pallavi Bhatevara
Designation
Managing Director
Contact Number Of Contact Person
+91 20 2740 2400
Email Of Contact Person
investors@krsnaa.in
13
Reporting boundary - Are the disclosures under 
this report made on a standalone basis (i.e. only for 
the entity) or on a consolidated basis (i.e. for the 
entity and all the entities which form a part of its 
Standalone basis
83
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
II. Products/services
 
14. Details of business activities
S. No.
Description of main activity Description of business activity
% of turnover
1
Diagnostic and Related 
Healthcare Services
The Company is primarily engaged in the business of providing 
Diagnostic Services primarily in relation to Pathology Investigation, 
Radiology Investigation and Telereporting.
100%
 
15. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover):
S. No.
Product/Service
NIC Code
% of total Turnover contributed
1
Diagnostic and Related Healthcare Tests and Services
869
100%
III. Operations
Location
Number of plants
Total
National
-
8 
8
International
-
-
-
 
17. Markets served by the entity:
 
 
a. 
Number of locations
Location
Number
National (No. of States)*
19
International (No. of Countries)
-
 
 
 
* Includes Union Territories
 
 
b. 
What is the contribution of exports as a percentage of the total turnover of the entity? Nil
 
 
c. 
A brief on types of customers
 
 
 
 The Company’s Customer includes B2B and B2C Customers, Individual Patients, Hospitals and 
Government Clients.
IV. Employees
 
18. Details as at the end of Financial Year: 2022-23
S. No
Particulars
Total (A)
Male
Female
Others
No. (B)
% (B/A)
No. (C)
% (C/A)
No. (H)
% (H/A)
EMPLOYEES
1.
Permanent (D)
2,562
1,605
62.64%
957
37.35%
-
-
2.
Other than Permanent (E)
996
266
26.70%
730
73.29%
-
-
3.
Total employees (D + E)
3,558
1,871
52.58%
1,687
47.41%
-
-
WORKERS
4.
Permanent (F)
N/A
5.
Other than Permanent (G)
6.
Total workers (F + G)
84
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
S. No
Particulars
Total (A)
Male
Female
Others
No. (B)
% (B/A)
No. (C)
% (C/A)
No. (H)
% (H/A)
DIFFERENTLY ABLED EMPLOYEES
1.
Permanent (D)
2
2
100%
-
-
-
-
2.
Other than Permanent (E)
-
-
-
-
-
-
-
3.
Total employees (D + E)
2
2
100%
-
-
-
-
DIFFERENTLY ABLED WORKERS
4.
Permanent (F)
N/A
5.
Other than Permanent (G)
6.
Total workers (F + G)
 
19. Participation/Inclusion/Representation of women
Total (A)
No. and percentage of Females
No. (B)
% (B / A)
Board of Directors
8
2
25%
Key Management Personnel
5
1
20%
 
20. Turnover rate for permanent employees and workers
 
 
(Disclose trends for the past 3 years)
 FY 2022-23
 (Turnover rate in current FY)
 FY 2021-22 
(Turnover rate in previous FY)
 FY 2020-21 
(Turnover rate in the year  
prior to the previous FY)
Male
Female Others
Total
Male
Female
Others
Total
Male
Female
Others
Total
Permanent 
Employees
29.35%
11.25%
40.70%
21.78%
11.30%
33.08%
10.148%
3.76%
0
13.90%
Permanent 
Workers
-
-
-
-
-
-
-
-
-
-
-
-
V. Holding, Subsidiary and Associate Companies (including joint ventures)
 
21.  (a) Names of holding / subsidiary / associate companies / joint ventures
S. No.
Name of the holding/Subsidiary/associate 
companies/ joint ventures (A)
Indicate whether 
holding/
subsidiary/
Associate/Joint 
venture
& of 
shares 
held by 
Listed 
entity
Does the entity indicated 
at column A, participate in 
the Business responsibility 
initiatives of the listed 
entity? (Yes/No)
1
KDPL Diagnostics (Ludhiana) Private Limited
Subsidiary
100%
No
2
KDPL Diagnostics (Amritsar) Private Limited
Subsidiary
100%
No
3
KDPL Diagnostics (Bathinda) Private Limited
Subsidiary
100%
No
4
KDPL Diagnostics (Jalandhar) Private Limited
Subsidiary
100%
No
5
KDPL Diagnostics (Patiala) Private Limited
Subsidiary
100%
No
6
KDPL Diagnostics (SAS Nagar) Private Limited
Subsidiary
100%
No
7
Krsnaa Diagnostics (Mohali) Private Limited
Subsidiary
100%
No
85
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
VI. CSR Details
 
22. CSR Details
Whether CSR is applicable as per section 135 of Companies Act, 2013
Yes
Turnover (in `)
4,640.83 million
Net worth (in `)
7,425.01 million
VII. Transparency and Disclosures Compliances
 
23.  Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines 
on Responsible Business Conduct:
Stakeholder 
group from 
whom 
complaint is 
received
Grievance Redressal 
Mechanism in Place 
(Yes/No)
 FY 2022-23
 FY 2021-22
Number of 
complaints 
during the 
year
Number of 
complaints 
pending 
resolution 
at close of 
the year
Remarks
Number of 
complaints 
during the 
year
Number of 
complaints 
pending 
resolution 
at close of 
the year
Remarks
Communities
No
The Company did not receive any Complaints from Community
Investors 
(other than 
shareholders)
Yes. The Company has 
a Investor Grievance 
Redressal Mechanism. 
Investors can visit www.
krsnaadiagnostics.com/
investors/ and register 
their grievances.
-
-
NA
-
-
NA
Shareholders
Yes. The Company has a 
Shareholder Grievance 
Redressal Mechanism. 
Shareholders can email 
investors@krnsaa.in and 
can reach to 020-2740 
2400
17
-
NA
5,341
-
NA
Employees 
and workers
Yes. The Company has 
an internal grievance 
redressal policy. The 
Human Resource team 
has a dedicated email for 
registering complaints. 
The Company also has 
whistle blower policy along 
with dedicated Committee 
for addressing complaints 
of Sexual Harassment; if 
any.
-
-
NA
-
-
NA
Customers
Yes, a dedicated helpline 
number 020-6814 6814 
is setup to receive and 
address the complaints 
of the Customers. 
Alternatively, an Email ID 
enquiry@krsnaa.in is setup 
for customer complaints.
17
-
NA
121
-
NA
Value Chain 
Partners
Yes
-
-
NA
-
-
NA
86
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
 
24. Overview of the entity’s material responsible business conduct issues
 
 
 Please indicate material responsible business conduct and sustainability issues pertaining to 
environmental and social matters that present a risk or an opportunity to your business, rationale for 
the following format
S. 
No.
Material 
issue 
Indicate 
whether 
risk or 
opportunity 
(R/O)
Rationale for 
identifying the 
risk/opportunity
In case of risk, approach to adapt 
or mitigate
Financial implications 
of the risk or 
opportunity (Indicate 
positive or negative 
implications)
1
Governance
Opportunity
The Company 
ensures highest 
level of Corporate 
Governance and 
Compliances with 
the statutory 
authorities.
-
Positive Implications
2
Health and 
Safety
Risk
technician
The Company ensures safe and 
healthy atmosphere by providing 
appropriate training and safety 
equipments.
Negative and Positive 
Implications
3
Cyber 
security
Risk
Patient data
The Company ensures highest level of 
cyber security and data encryptions. 
The company has also in the process 
of forming of IT steering committee 
to overview the IT security measures 
along-with other IT matters.
Negative Implications
4
Waste 
Management
Risk
Generation of Bio-
medical Waste.
Waste disposed of through 
Government Authorized channels. 
The Company maintain world class 
safety measures till the waste is 
handed over to such channels.
Negative Implications
5
Energy 
Management
Opportunity
Medical 
equipments used 
in our business 
are usually high 
energy consuming 
equipments.
The Company strives to procure 
reduce power consumptions and also 
use energy reducing techniques.
Positive Implications
87
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
SECTION B: Management and Process Disclosures
This section is aimed at helping businesses demonstrate the structures, policies and processes put 
in place towards adopting the NGRBC Principles and Core Elements.
P1
Businesses should conduct and govern themselves with integrity in a manner that is ethical, transparent and accountable
P2
Businesses should provide goods and services in a manner that is sustainable and safe
P3
Businesses should respect and promote the well-being of all employees, including those in their value chains
P4
Businesses should respect the interests of and be responsive towards all its stakeholders
P5
Businesses should respect and promote human rights
P6
P7
transparent
P8
Businesses should promote inclusive growth and equitable development
P9
Businesses should engage with and provide value to their consumers in a responsible manner
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
Policy and management processes
1. a.  Whether your entity’s policy/policies cover each principle 
and its core elements of the NGRBCs. (Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
 
b. Has the policy been approved by the Board? (Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
 
c. Web Link of the Policies, if available
www.krsnaadiagnostics.com/investors/
2.  Whether the entity has translated the policy into procedures. 
(Yes / No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
3.  Do the enlisted policies extend to your value chain partners? 
(Yes/No)
Yes*
Yes*
Yes*
Yes*
Yes*
Yes*
Yes*
Yes*
Yes*
labels/ standards (e.g. Forest Stewardship Council, Fairtrade, 
Rainforest Alliance, Trustea) standards (e.g. SA 8000, OHSAS, 
ISO, BIS) adopted by your entity and mapped to each 
principle.
All policies conform to the applicable laws of the country, 
SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015, and National Guidance on Responsible 
Business Conduct.
The Company is committed in implementing NGRBCs its 
true sprit along with other ESG initiatives which includes 
with regards to Bio Medical wastes, water management 
and other such initiatives. The Company is also in process 
of formulizing targets and road map to achieve the above 
initiatives and the Company will continue to monitor its 
progress on the above mentioned initiatives.
goals and targets along-with reasons in case the same are 
not met.
The Company is continuously implementing process 
improvements to reduce emissions and wastages. In line 
with the Company’s commitment towards conservation 
wastage, optimise consumption and also to improve 
88
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
 
Governance, leadership and oversight
7.  Statement 
by 
director 
responsible 
for the 
business 
responsibility report, highlighting ESG related challenges, 
targets and achievements
sustainability a priority and adopting responsible 
business practices are essential cornerstones for our 
enduring success. We understand the pressing nature 
change, social inequalities, and ethical governance. Our 
recognition extends beyond mere acknowledgment; we 
comprehend that sustainable business practices not 
only serve the planet and society but also act as catalysts 
for innovation, heightened competitiveness, and the 
protection of our reputation. In light of this, we have 
executed an extensive array of sustainability initiatives 
that span the entirety of our operations. These initiatives 
employee well-being, community engagement and 
ethical governance.
As we gaze into the future, our dedication to sustainability 
and the pursuit of ESG excellence remains steadfast. We 
will continue to infuse sustainable practices throughout 
our value chain, embrace emerging technologies and 
exemplar methodologies. 
8.  Details 
of 
the 
highest 
authority 
responsible 
for 
implementation and oversight of the Business Responsibility 
policy (ies).
Ms. Pallavi Bhatevara, Managing Director
DIN: 03600332
Email: investors@krsnaa.in
T.: 020 2740 2400
Director responsible for decision making on sustainability 
related issues? (Yes / No).
No
*The Company encourages all its value chain partners to follow the Business Responsibility Policies to the extent possible.
10. Details of Review of NGRBCs by the Company:
Subject for Review
Indicate whether review was undertaken by Director 
/ Committee of the Board / Any other Committee
P1
P2
P3
P4
P5
P6
P7
P8
P9
Performance against above policies and follow up action Indicate 
whether review was undertaken by Director / Committee of the 
Board/Any other Committee
Director
Compliance with statutory requirements of relevance to the 
whether review was undertaken by Director / Committee of the 
Board/Any other Committee
Director
Subject for Review
Frequency (Annually/ Half yearly/ Quarterly/ Any 
other - please specify)
Performance against above policies and follow up action Frequency 
(Annually/ Half yearly/ Quarterly/ Any other - please specify)
Ongoing
Compliance with statutory requirements of relevance to the 
(Annually/ Half yearly/ Quarterly/ Any other - please specify)
Ongoing
11.  Has the entity carried out independent assessment/ evaluation of the working of its policies by an 
external agency? (Yes/No). If yes, provide name of the agency.
 
No
89
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
12.  If answer to question (1) above is “No” i.e. not all Principles are covered by a policy, reasons to be 
stated:
Question
P1
P2
P3
P4
P5
P6
P7
P8
P9
The entity does not consider the Principles material to its business 
(Yes/No)
NA
The entity is not at a stage where it is in a position to formulate and 
resources available for the task (Yes/No)
Any other reason (please specify)
Section C : Principle Wise Performance Disclosure
PRINCIPLE 1
Businesses should conduct and govern themselves with integrity, and in a manner that is Ethical, 
Transparent and Accountable.
Essential Indicators
1. 
 Percentage coverage by training and awareness programmes on any of the Principles during the 
Segment
Total number of 
training and awareness 
programmes held
Topics / principles covered under the 
training and its impact
%age of persons in 
respective category 
covered by the 
awareness programmes
Board of Directors
5
Industry Overview, Business Strategy, Cyber 
Security related.
95%
Key Managerial 
Personnel
5
Industry Overview, Business Strategy, 
Corporate Governance, ESG
100%
Employees other than 
BoD and KMPs
130
SOP Training, Safety Training, Departmental 
Procedures training, Knowledge enhancement 
training, HR practices and Policies Training
100%
Workers
NA
NA
NA
proceedings (by the entity or by directors / KMPs) with regulators/ law enforcement agencies/ judicial 
Obligations) Regulations, 2015 and as disclosed on the entity’s website):
Principals
Monetary
NGRBC 
Principle
Name of the regulatory/ 
enforcement agencies/ 
judicial institutions
Amount (In `)
Brief of the 
Case
Has an appeal been 
preferred? (Yes/No)
Penalty/ Fine
-
-
-
-
-
Settlement
-
-
-
-
-
Compounding fee
-
-
-
-
-
90
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
Non-Monetary
Principals
NGRBC 
Principle
Name of the regulatory/ enforcement 
agencies/ judicial institutions
Brief of the 
Case
Has an appeal been 
preferred? (Yes/No)
Imprisonment
-
-
-
-
Punishment
-
-
-
-
3. 
 Of the instances disclosed in Question 2 above, details of the Appeal/ Revision preferred in cases 
where monetary or non-monetary action has been appealed.
 
NA
4. 
Does the entity have an anti-corruption or anti-bribery policy?
 
Yes. The Company has the policy and is available on www.krsnaadiagnostics.com/investors
5. 
 Number of Directors/KMPs/employees/workers against whom disciplinary action was taken by any 
law enforcement agency for the charges of bribery/ corruption:
 FY 2022-23
 FY 2021-22
Directors
KMPs
Employees
Workers
 FY 2022-23
 FY 2021-22
Number
Remarks
Number
Remarks
Interest of the Directors
Interest of the KMPs
action taken by regulators/ law enforcement agencies/ judicial institutions, on cases of corruption 
 
NA
Leadership Indicators
the Board? (Yes/No) If Yes, provide details of the same:
 
 Yes, the Company has implemented a Code of Conduct that applies to the Board of Directors, Key Managerial 
Personnel and other members of Senior Management. This code provided clear guidelines for identifying, avoiding, 
 
 Furthermore, the Company ensures that all necessary approvals required by applicable laws are obtained before 
engaging in transactions with any related entities.
 
 To ensure transparency and Compliance, the Company obtains an annual declaration from the individual Directors, 
Key Managerial Personnel and Senior Management regarding their interest in other entities that could give rise to 
91
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
PRINCIPLE 2
Businesses should provide goods and services in a manner that is sustainable and safe
Essential Indicators
the environmental and social impacts of product and processes to total R&D and capex investments 
made by the entity, respectively.
 FY 2022-23
 FY 2021-22
Details of improvements in environmental and social impacts
R&D
-
-
-
Capex
-
-
-
 
The Company is currently not maintaining this data separately; this data will be available from subsequent years.
2. 
a. 
Does the entity have procedures in place for sustainable sourcing?
 
b. 
If yes, what percentage of inputs were sourced sustainably?
 
 
 We view sustainability as a pathway to attain leadership and create enduring value for our stakeholders. 
Our commitment lies in integrating sustainability into every business decision throughout our value chain. 
Additionally, we actively collaborate with various stakeholders to strengthen our sustainable sourcing strategies.
3. 
 Describe the processes in place to safely reclaim your products for reusing, recycling and disposing 
at the end of life, for
 
- E-waste: Sent to Authorized recyclers;
 
- hazardous Waste: Sent to Biomedical Waste Management System (BMW);
 
- Other Waste: Sent to Authorized recyclers.
4. 
Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes / No).
 
N/A
PRINCIPLE 3
Businesses should respect and promote the well-being of all employees, including those in their value 
chains
Essential Indicators
1. 
a. 
Details of measures for the well-being of employees:
Category
% of employees covered by
Total 
(A)
Health insurance
Accident 
insurance
Maternity 
Paternity 
Day Care 
facilities
Number 
(B)
% (B / 
A)
Number 
(C)
% (C / 
A)
Number 
(D)
% (D / 
A)
Number 
(E)
% (E / 
A)
Number 
(F)
% (F / 
A)
Permanent employees
Male
1,605
1,605
100%
1,605
100%
-
-
0
-
0
-
Female
957
957
100%
957
100%
957
100%
0
-
0
-
Total
2,562
2,562
100%
2,562
100%
957
100%
0
-
0
-
Other than Permanent employees
Male
N/A
Female
Total
92
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
 
b. 
Details of measures for the well-being of workers:
Category
% of workers covered by
Total (A)
Health 
insurance
Accident 
insurance
Maternity 
Paternity 
Day Care 
facilities
Number 
(B)
% (B 
/ A)
Number 
(C)
% (C / 
A)
Number 
(D)
% (D 
/ A)
Number 
(E)
% (E / 
A)
Number 
(F)
% (F 
/ A)
Permanent workers
Male
N/A
Female
Total
Other than Permanent workers
Male
N/A
Female
Total
FY 2022-23
FY 2021-22
No. of employees 
covered as a % of 
total employees
No. of workers 
covered as 
a % of total 
workers
Deducted and 
deposited with 
the authority 
(Y/N/N.A.)
No. of employees 
covered as a % of 
total employees
No. of workers 
covered as 
a % of total 
workers
Deducted and 
deposited with 
the authority 
(Y/N/N.A.)
PF
100%
NA
Yes
100%
NA
Yes
Gratuity
100%
NA
Yes
100%
NA
Yes
ESI
100%
NA
Yes
100%
NA
Yes
Others - please specify
3. 
Accessibility of workplaces
requirements of the Rights of Persons with Disabilities Act, 2016?
of the Rights of Persons with Disabilities act, 2016
4.   Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act, 
2016?
 
 Yes, the Company has the Policy in place which forms a part of the HR Manual of the Company available at the 
intranet of the Company.
5. 
 Return to work and Retention rates of permanent employees and workers that took parental leave.
Permanent employees
Permanent workers
Gender
Return to work rate
Retention rate
Return to work rate
Retention rate
Male
100.00%
100.00%
-
-
Female
74.23%
70.50%
-
-
Total
87.10%
85.25%
-
-
93
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
6. 
 Is there a mechanism available to receive and redress grievances for the following categories of 
employees and worker?
 
Yes
Yes/No (If Yes, then give details of the mechanism in brief)
Permanent Workers
The Company has the HRMS software in place. Employees can raise their 
grievances through the software and the raised grievance is resolved by the 
concerned department heads as per the HR policy of the Company.
Other than Permanent Workers
Permanent Employees
Other than Permanent Employees
7. 
Membership of employees and worker in association(s) or Unions recognized by the listed entity:
Category
FY 2022-23
FY 2021-22
Total 
employees 
/ workers in 
respective 
category (A)
No. of employees / 
workers in respective 
category, who are part of 
association(s) or Union 
(B)
% (B 
/ A)
Total 
employees 
/ workers in 
respective 
category (C)
No. of employees / 
workers in respective 
category, who are part of 
association(s) or Union 
(D)
% (D 
/ C)
Total Permanent 
Employees
NIL
- Male
- Female
- Others
Total Permanent 
Workers
- Male
- Female
- Others
8. 
Details of training given to employees and workers:
Category
 FY 2022-23
 FY 2021-22
Total 
(A)
On Health and safety 
measures
On Skill 
upgradation
Total 
(D)
On Health and safety 
measures
On Skill 
upgradation
No. (B)
% (B / A)
No. (C)
% (C / A)
No. (E)
% (E / D)
No. (F)
% (F / D)
Employees
Male
1,605
1,410
87.85
1,540
95.95
1,459
1,170
80.19
1,240
85.00
Female
957
902
94.25
934
97.60
535
380
71.03
481
90.00
Others
-
-
-
-
-
-
-
-
-
-
Total
2,562
2,312
90.24
2,474
96.57
1,994
1,550
77.73
1,721
86.31
WORKERS
Male
N/A
Female
Others
Total
94
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
9. 
Details of performance and career development reviews of employees and worker:
Category
FY 2022-23
FY 2021-22
Total (A)
No. (B)
% (B / A)
Total (C)
No. (D)
% (D / C)
Employees
Male
1,605
1,605
100
1,459
1,459
100
Female
957
957
100
535
535
100
Others
-
-
-
-
-
-
Total
2,562
2,562
100
1,994
1,994
100
Workers
Male
N/A
Female
Others
Total
10. Health and safety management system:
 
a. 
 Whether an occupational health and safety management system has been implemented by the entity? (Yes/ 
No).
 
b.   What are the processes used to identify work-related hazards and assess risks on a routine and non-routine 
basis by the entity?
 
 
 The Company periodically reviews matters related to work hazards and has developed guidelines and procedures 
to address them. This is an ongoing activity in the Company. The center managers oversee the implementation 
of the procedures on a daily basis.
 
c. 
 Whether you have processes for workers to report the work related hazards and to remove themselves 
from such risks. (Y/N)
 
 
Not applicable.
 
d. 
 Do the employees/ worker of the entity have access to non-occupational medical and healthcare services? 
(Yes/ No)
 
 
Yes, the Company provides Mediclaim coverage or ESIC as per applicability.
11. Details of safety related incidents, in the following format:
Safety Incident/Number
Category
 FY 2022-23
 FY 2021-22
Lost Time Injury Frequency Rate (LTIFR) (per one million-
person hours worked)
Employees
-
-
Workers
-
-
Total recordable work-related injuries
Employees
-
-
Workers
-
-
No. of fatalities
Employees
-
-
Workers
-
-
High consequence work-related injury or ill-health 
(excluding fatalities)
Employees
-
-
Workers
-
-
95
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
12. Describe the measures taken by the entity to ensure a safe and healthy work place.
 
 The Company has a standard safety precaution guideline at every center of the Company and the center manager 
is responsible for implementation of the same at every Center. All safety protocols while processing samples are 
13. Number of Complaints on the following made by employees and workers:
FY 2022-23
FY 2021-22
Filed during 
the year
Pending resolution 
at the end of year
Remarks
Filed during 
the year
Pending resolution 
at the end of year
Remarks
Working Conditions
-
-
-
-
-
-
Health & Safety
-
-
-
-
-
-
14. Assessments for the year:
third parties)
Health and safety practices-
100
Working Conditions-
100
15.  Provide details of any corrective action taken or underway to address safety-related incidents (if any) 
conditions.
 
Not applicable
Leadership Indicators
1. 
 Does the entity extend any life insurance or any compensatory package in the event of death of (A) 
Employees (Yes/No) (B) Workers(Yes/No):
 
 The management of the Company places a high priority on the well-being of its employees. In the event of an 
unfortunate death of an employee or worker, the Company is committed to supporting the next of kin and the 
support they require.
PRINCIPLE 4
Businesses should respect the interests of and be responsive to all its stakeholders
Essential Indicators
1. 
Describe the processes for identifying key stakeholder groups of the entity.
 
Below is the list of internal and external stakeholders:
 
- Employees;
 
- Local Communities;
 
- Regulatory Authorities;
 
- Customers;
 
- Shareholders;
 
- Suppliers and other Business partners;
 
- Franchised Lab Partner
96
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
stakeholder group.
Stakeholder 
Group
Whether 
Vulnerable & 
Marginalized 
Group (Yes/No)
Channels of communication 
(Email, SMS, Newspaper, 
Pamphlets, Advertisement, 
Community Meetings, Notice 
Board, Website), Other
Frequency of 
engagement 
(Annually/ Half yearly/ 
Quarterly / others - 
please specify)
Purpose and scope of 
engagement including key 
topics and concerns raised 
during such engagement
Employee
No
Email, SMS, Town Halls 
Meetings, all Hand Meetings/
Meetings
Daily, Weekly
Monthly, Quarterly, Half 
Yearly and Yearly
- 
KRA and KPI Goal,
- 
Sales and Operation,
- 
 performance Corporate 
Culture,
- 
Ethical Business Conducts,
- 
 Competitive rewards and 
remuneration
Local 
Communities
Yes
CSR Meeting
Annually
Contributions and Community 
developments programmes 
through CSR initiatives
Regulatory 
Authorities
No
E-mails, Letters
Whenever required
- 
 Statutory and regulatory 
Compliances
Customers
No
Surveys, Email, SMS, Website, 
Corporate Brochure, digital 
media, Advertisement and In-
person Meeting
Monthly
Promotional Schemes, New 
Tests
Shareholders
No
Email, Newspaper, Notice,
Website, Board Meetings and 
Shareholders Meeting
Quarterly, Half
Yearly and
Annually
- 
Corporate Governance,
- 
Financial Results,
- 
Regulatory Compliances,
- 
 other Corporate 
Announcements
Suppliers and 
other Business 
partners
No
Emails, In-person Meeting, 
Letters
Whenever required
- 
 Pricing and favorable 
terms of payments
- 
Timely Clearance
Franchised Lab 
Partner
No
Emails, Surveys, In-person 
Meeting
Monthly
- 
Promotional Schemes
Leadership Indicators
1. 
 Provide details of instances of engagement with, and actions taken to, address the concerns of 
vulnerable/ marginalized stakeholder groups.
 
 Community, that the Company is a part of is an important stakeholder to the Business. The Company, having worked 
embarks upon multiple, structured and well planned CSR projects. The CSR projects of the Company aims to focus on 
a preventive healthcare and other areas of healthcare our disadvantaged, vulnerable and marginalised stakeholders. 
The Company ensures that the CSR Funds are utilised in an optimum manner that serves the weaker sections of the 
society in terms of healthcare.
97
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
PRINCIPLE 5
Businesses should respect and promote human rights
Essential Indicators
1. 
 Employees and workers who have been provided training on human rights issues and policy(ies) of 
the entity, in the following format:
Category
FY 2022-23
FY 2021-22
Total 
(A)
No. of employees/ workers 
covered (B)
% (B / 
A)
Total 
(C)
No. of employees/ workers 
covered (D)
% (D / 
C)
Employees
Permanent
2,562
2,305
89.97
1,994
1,495
74.97
Other than 
permanent
996
847
85.04
1,014
710
70.02
Total Employees
3,558
3,152
88.59
3,008
2,205
73.30
Workers
Permanent
N/A
Other than 
permanent
Total Workers
2. 
Details of minimum wages paid to employees and workers, in the following format:
Category
FY 2022-23
FY 2021-22
Total 
(A)
Equal to Minimum 
Wage
More than 
Minimum Wage
Total 
(D)
Equal to Minimum 
Wage
More than 
Minimum Wage
No. (B)
% (B / A)
No. (C)
% (C / A)
No. (E)
% (E / D)
No. (F)
% (F / D)
Employees
Permanent
2,562
0
0
2,562
100.00
1,994
0
0
1,994
100.00
Male
1,605
0
0
1,605
100.00
1,459
0
0
1,459
100.00
Female
957
0
0
957
100.00
535
0
0
535
100.00
Others
0
0
0
0
0.00
0
0
0
0
0.00
Other than 
permanent
996
90
-
-
-
625
128
-
-
-
Male
266
64
24.06
0
0.00
322
80
24.84
0
0.00
Female
730
26
03.56
0
0.00
293
48
16.38
0
0.00
Others
-
-
-
-
-
-
-
-
-
-
Workers
Permanent
N/A
Male
Female
Others
Other than 
permanent
Male
Female
Others
98
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
3. 
Details of remuneration/salary/wages, in the following format:
Male
Female
Number
Median remuneration/ salary/ 
wages of respective category
Number
Median remuneration/ salary/ 
wages of respective category
Board of Directors (BoD)
6
6,50,000
2
23,98,054
Key Managerial 
Personnel
4
39,02,614
1
40,96,108
Employees other than 
BoD and KMP
2,303
2,16,072
1,949
1,74,204
Workers
-
-
-
-
4. 
 Do you have a focal point (Individual/ Committee) responsible for addressing human rights impacts 
or issues caused or contributed to by the business? (Yes/No)
 
 Yes, the responsibility of recording and addressing human rights issues lies with the Human Resource team. However, 
the Company proactively focuses on prevention by providing training to employees on understanding human rights, 
recognizing its various forms, and the appropriate reporting procedures.
5. 
Describe the internal mechanisms in place to redress grievances related to human rights issues.
 
 Any grievance regarding to human rights are reported to the Human Resource Team through a dedicated email 
id. The HR team validates the grievance and forwards the same to the internal committee for its consideration and 
action. The committee has to resolve the grievance within a stipulated timeline as mentioned in the HR Policy of 
the Company
6. 
Number of Complaints on the following made by employees and workers:
FY 2022-23
FY 2021-22
Filed during 
the year
Pending resolution 
at the end of year
Remarks
Filed during 
the year
Pending resolution 
at the end of year
Remarks
Sexual Harassment
-
-
-
-
-
-
Discrimination at 
workplace
-
-
-
-
-
-
Child Labour
-
-
-
-
-
-
Forced Labour/Involuntary 
Labour
-
-
-
-
-
-
Wages
-
-
-
-
-
-
Other human rights 
related issues
-
-
-
-
-
-
7. 
 Mechanisms to prevent adverse consequences to the complainant in discrimination and harassment 
cases.
 
 The Company maintains a culture of open communication that fosters a respectful and harassment-free environment.
 
 The Whistleblower Policy serves as a guideline and mechanism for protecting individuals who raise complaints or 
act as whistleblowers. Any complaints or disclosures made by whistleblowers are thoroughly investigated, ensuring 
 
 The Company takes all necessary precautions to safeguard the identity of the complainant or whistleblower. This 
their identity. The Company provides necessary safeguards to whistleblowers, allowing them to make protected 
99
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
disclosures in good faith regarding various areas outlined in the Code of Conduct. In relation to sexual harassment, 
the Company strictly adheres to the principles of Prohibition, Prevention, and Redressal, as outlined in the Sexual 
Harassment of Women at Workplace (Prevention, Prohibition, and Redressal) Act, 2013 (POSH) and the corresponding 
identity of the complainant. The Company has established a POSH committee in compliance with the provisions 
of the Act.
8. 
Do human rights requirements form part of your business agreements and contracts? (Yes/No)
 
No
9. 
Assessments for the year:
or third parties)
Child labour
100
Forced/involuntary labour
100
Sexual harassment
100
Discrimination at workplace
100
Wages
100
Others - please specify
100
arising from the assessments at Question 9 above.
 
Not Applicable
Leadership Indicators
grievances/complaints.
 
 No complaints have been received during the Financial Year under review. Accordingly, no business processes have 
2. 
Details of the scope and coverage of any human rights due-diligence conducted.
 
 The Company has established strong practices to actively discourage not just human rights but also other kinds of 
behavior that may be in contravention to the Company’s Ethics policy and Code of Conduct.
the Rights of Persons with Disabilities Act, 2016?
 
 Yes, The Company strongly believes in the idea of providing equal opportunities to all its employees’ and in lines with 
100
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
PRINCIPLE 6
Essential Indicators
1. 
 Details of total energy consumption (in Joules or multiples) and energy intensity, in the following 
format:
Parameter
Please specify unit
 FY 2022-23
 FY 2021-22
Total electricity consumption (A)
G Joules
25,747
19,694
Total fuel consumption (B)
G Joules
48
43
Energy consumption through other sources (C)
G Joules
101
-
Total energy consumption (A+B+C)
G Joules
25,895
19,737
Energy intensity per rupee of turnover (Total energy 
consumption/ turnover in Crore rupees)
G Joules
55.80
43.39
Energy intensity (optional) - the relevant metric may be 
selected by the entity
G Joules
-
-
 
 Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? 
(Y/N)
Performance, Achieve and Trade (PAT) Scheme of the Government of India? (Y/N)
 
The company/units does not fall into a category of energy-intensive industries. Hence, PAT scheme is not applicable.
3. 
Provide details of the following disclosures related to water, in the following format:
Parameter
Please specify unit
 FY 2022-23
 FY 2021-22
Water withdrawal by source (in kilolitres)
(i) Surface water
kilolitres
-
-
(ii) Groundwater
kilolitres
-
-
(iii) Third party water
kilolitres
24,794
28,045
(iv) Seawater / desalinated water
kilolitres
-
-
(v) Others
kilolitres
-
-
Total volume of water withdrawal (in kilolitres) (i + ii + iii 
+ iv + v)
kilolitres
24,794
28,045
Total volume of water consumption (in kilolitres)
kilolitres
24,794
28,045
Water intensity per rupee of turnover (Water consumed / 
Crore ` turnover)
kilolitres
53.43
61.65
Water intensity (optional) - the relevant metric may be 
selected by the entity
kilolitres
-
-
 
 Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? 
(Y/N): No
 
If yes, name of the external agency.
4. 
Has the entity implemented a mechanism for Zero Liquid Discharge? No
101
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
5. 
 Please provide details of air emissions (other than GHG emissions) by the entity, in the following 
format:
Parameter
Please specify unit
 FY 2022-23
 FY 2021-22
NOx
The company has not tracked air 
emissions this year; however, plans to 
work on it in the subsequent years.
SOx
Particulate matter (PM)
Persistent organic pollutants (POP)
Volatile organic compounds (VOC)
Hazardous air pollutants (HAP)
Others - please specify
 
 Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? 
(Y/N)
 
No
6. 
 Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity, in the 
following format:
Parameter
Unit
 FY 2022-23
 FY 2021-22
Total Scope 1 emissions ( Break-up of the GHG into CO 2, 
CH4, N2O, HFCs, PFCs, SF6, NF3, if available)
CO2 in Metric tonnes
27.79
20.39
Total Scope 2 emissions ( Break-up of the GHG into CO 2, 
CH4, N2O, HFCs, PFCs, SF6, NF3, if available)
CO2 in Metric tonnes
89.38
86.49
Total Scope 1 and Scope 2 emissions per Crore of turnover
CO2 in Metric tonnes
117.17
106.88
Total Scope 1 and Scope 2 emission intensity (optional) - the 
relevant metric may be selected by the entity
CO2 in Metric tonnes
0.25
0.23
 
 Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? 
(Y/N): No
 
If yes, name of the external agency. 
7. 
Does the entity have any project related to reducing Green House Gas emission?
8. 
Provide details related to waste management by the entity, in the following format:
Parameter
Parameter
 FY 2022-23
 FY 2021-22
Total Waste generated (in metric tonnes)
Plastic waste (A)
metric tonnes
-
-
E-waste (B)
metric tonnes
0.78
0.95
Bio-medical waste (C)
metric tonnes
17.938
34.084
Construction and demolition waste (D)
metric tonnes
-
-
Battery waste (E)
metric tonnes
18.59
8.37
Radioactive waste (F)
metric tonnes
-
-
Other Hazardous waste. Please specify, if any. (G)
metric tonnes
-
-
102
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
Parameter
Parameter
 FY 2022-23
 FY 2021-22
Other Non-hazardous waste generated (H). Please specify, 
if any. (Break-up by composition i.e. by materials relevant to 
the sector)
metric tonnes
-
-
Total (A+B + C + D + E + F + G + H)
metric tonnes
37.308
43.404
For each category of waste generated, total waste recovered through recycling, re-using or other recovery operations (in 
metric tonnes)
Category of waste
(i)  Recycled
metric tonnes
-
-
(ii)  Re-used
metric tonnes
-
-
(iii)  Other recovery operations
metric tonnes
-
-
Total
metric tonnes
-
-
For each category of waste generated, total waste disposed by nature of disposal method (in metric tonnes)
Category of waste
(i)  Incineration
metric tonnes
-
-
metric tonnes
-
-
(iii)  Other disposal operations
metric tonnes
-
-
Total
metric tonnes
-
-
 
 Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? 
(Y/N): No
 
If yes, name of the external agency. 
strategy adopted by your company to reduce usage of hazardous and toxic chemicals in your products 
and processes and the practices adopted to manage such wastes.
 
 Biomedical waste generated is systematically segregated in accordance with the Bio-Medical Waste Management 
Rules of 2016. The waste is then handed over to a state pollution control authorized vendor for secure disposal.
wildlife sanctuaries, biosphere reserves, wetlands, biodiversity hotspots, forests, coastal regulation 
zones etc.) where environmental approvals / clearances are required, please specify details in the 
following format: Not Applicable
11.  Details of environmental impact assessments of projects undertaken by the entity based on applicable 
Not Applicable
12.  Is the entity compliant with the applicable environmental law/ regulations/ guidelines in India; such 
as the Water (Prevention and Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, 
Environment protection act and rules thereunder (Y/N).
 
The company complies with all the regulatory environmental laws
103
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
Leadership Indicators
1. 
 Provide break-up of the total energy consumed (in Joules or multiples) from renewable and non-
renewable sources, in the following format:
Parameter
Please specify unit
 FY 2022-23
 FY 2021-22
From renewable sources
Total electricity consumption (A)
G Joules
101
0
Total fuel consumption (B)
G Joules
-
-
Energy consumption through other sources (C)
G Joules
-
-
other sources
Total energy consumed from renewable sources (A+B+C)
G Joules
101
0
From non-renewable sources
Total electricity consumption (D)
G Joules
25,747
19,694
Total fuel consumption (E)
G Joules
48
43
Energy consumption through other sources (F)
G Joules
-
-
other sources
Total energy consumed from non-renewable sources 
(D+E+F)
G Joules
25,795
19,737
 
 Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an 
external agency? (Y/N)
 
No
PRINCIPLE 7
responsible and transparent
Essential Indicators
 
b. 
 List the top 10 trade and industry chambers/ associations (determined based on the total 
S. No.
Name of the trade and industry chambers/ associations
Reach of trade and industry chambers/ 
associations (State/National)
1
Federation of Indian Chambers of Commerce and Industry (FICCI)
National
2.
NATHealth (Healthcare Federation of India)
National
2 
 Provide details of corrective action taken or underway on any issues related to anti-competitive 
conduct by the entity, based on adverse orders from regulatory authorities: Not Applicable
PRINCIPLE 8
Businesses should promote inclusive growth and equitable development
Essential Indicators
1. 
 Details of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable 
Not Applicable
2. 
 Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being 
undertaken by your entity, in the following format: Not Applicable
104
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
3. 
Describe the mechanisms to receive and redress grievances of the community.
 
The Company has a Whistle Blower Policy to receive and redress the grievances of the community.
4. 
Percentage of input material (inputs to total inputs by value) sourced from suppliers:
Parameter
 FY 2022-23
 FY 2021-22
Directly sourced from MSMEs/ small producers
5.69%
6.15%
Sourced directly from within the district and neighbouring districts
-
-
Leadership Indicators
S. No.
CSR Project
 
from CSR Projects
and marginalized groups
1.
Preventive Healthcare and Healthcare 
Initiatives
10,000
85
PRINCIPLE 9
Businesses should engage with and provide value to their consumers in a responsible manner
Essential Indicators
1. 
Describe the mechanisms in place to receive and respond to consumer complaints and feedback.
 
 The Company has a dedicated email address viz. enquiry@krsnaa.in and a dedicated helpline number viz. 020 6814 
6814 on which Patients or Customers can raise their complaints/ grievances. once the compliant(s) are logged it 
is assigned to the respective department. On resolution of the complaints/ grievances the respective Patients/
Customer is informed about the same.
2. 
 Turnover of products and/ services as a percentage of turnover from all products/service that carry 
information about:
As a percentage to total turnover
Environmental and social parameters relevant to the product
-
Safe and responsible usage
-
Recycling and/or safe disposal
-
3. 
Number of consumer complaints in respect of the following:
FY 2022-23 
(Current Financial Year)
Remarks
FY 2021-22 
(Previous Financial Year)
Remarks
Received during 
the year
Pending resolution 
at end of year
Received during 
the year
Pending resolution 
at end of year
Data privacy
-
-
NA
-
-
NA
Advertising
-
-
NA
-
-
NA
Cyber-security
-
-
NA
-
-
NA
Delivery of essential 
services
-
-
NA
-
-
NA
Restrictive Trade 
Practices
-
-
NA
-
-
NA
Unfair Trade Practices
-
-
NA
-
-
NA
Other
17
0
NA
121
0
NA
105
Annual Report 2022-23
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
4.  Details of instances of product recalls on account of safety issues:
Number
Reasons for recall
Voluntary recalls
-
-
Forced recalls
-
-
5. 
 Does the entity have a framework/ policy on cyber security and risks related to data privacy? (Yes/
No)
 
The Policy is at the intranet of the Company.
6. 
 Provide details of any corrective actions taken or underway on issues relating to advertising, and 
delivery of essential services; cyber security and data privacy of customers; re-occurrence of instances 
of product recalls; penalty / action taken by regulatory authorities on safety of products / services.
 
NA
Leadership Indicators
1. 
 Channels / platforms where information on products and services of the entity can be accessed 
(provide web link, if available).
www.krsnaadiagnostics.com), Mobile app, by dialing its 
customer care number or by walking up to the local center.
2. 
 Steps taken to inform and educate consumers about safe and responsible usage of products and/or 
services.
 
 All Centers of the Company have banners, promoting prudent and safe use of its services. Additionally, for the 
diagnostics tests available for consumers of all ages posted on a regular basis on the Company’s Youtube, Facebook 
and Instagram Channel.
3. 
 Mechanisms in place to inform consumers of any risk of disruption/discontinuation of essential 
services.
 
The Company uses a feedback survey system that is intended to assess customer experience with the Krsnaa Brand.
4. 
Provide the following information relating to data breaches:
 
a. 
Number of instances of data breaches along-with impact
 
 
NA
 
 
Not Applicable
106
Krsnaa Diagnostics Limited
Financial 
Statements
Statutory
Reports
Corporate 
Overview
107-246
26-106
01-25
